What is the current valuation of the Heart Transplant Market as of 2024?

The Heart Transplant Market was valued at 12.33 USD Billion in 2024. Read More

What is the projected market size for the Heart Transplant Market by 2035?

The market is projected to reach 35.54 USD Billion by 2035. Read More

What is the expected CAGR for the Heart Transplant Market during the forecast period 2025 - 2035?

The expected CAGR for the Heart Transplant Market during 2025 - 2035 is 10.1%. Read More

Which application segment is projected to have the highest growth in the Heart Transplant Market?

The Coronary Artery Disease segment is projected to grow from 4.0 USD Billion in 2024 to 11.0 USD Billion by 2035. Read More

How does the market size for living donor transplants compare to deceased donor transplants?

In 2024, the market for living donor transplants was 4.93 USD Billion, while deceased donor transplants were valued at 7.4 USD Billion. Read More

What are the key players in the Heart Transplant Market?

Key players include Abbott, Medtronic, Boston Scientific, and Terumo Corporation, among others. Read More

Which end-use segment is expected to see the most significant growth by 2035?

The Hospitals segment is expected to grow from 4.93 USD Billion in 2024 to 14.14 USD Billion by 2035. Read More

What is the market size for pediatric heart transplants compared to adult and geriatric transplants?

Pediatric heart transplants were valued at 1.23 USD Billion in 2024, while adult and geriatric transplants were valued at 7.33 USD Billion and 3.77 USD Billion, respectively. Read More

How does the gender distribution in the Heart Transplant Market appear?

In 2024, the market for male heart transplant patients was 7.4 USD Billion, compared to 4.93 USD Billion for female patients. Read More

What trends are anticipated in the Heart Transplant Market by 2035?

The market is likely to experience substantial growth across all segments, driven by advancements in medical technology and increasing patient demand. Read More

Heart Transplant Market

ID: MRFR/MED/1304-HCR

80 Pages

Nidhi Mandole

Last Updated: May 15, 2026

Heart Transplant Market Research Report Information By Type (Ventricular Assisted Device, Total Artificial hearts and Others), By End User (Hospitals, Cardiac Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Heart Transplant Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.1%

2024 Market Size$ 12.33 Billion

2025 Market Size$ 13.58 Billion

2035 Market Size$ 35.54 Billion

Key Players

Medtronic

Abbott Laboratories

Boston Scientific

Terumo Corporation

Cardinal Health

Baxter International

Trends

Technological Advancements in Transplant Procedures
Growing Demand for Organ Transplantation
Focus on Post-Transplant Care

Opportunities

Aging Population
Market Growth Projections
Advancements in Medical Technology

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Cardiac Failure
  2. 4.1.2 Coronary Artery Disease
  3. 4.1.3 Congenital Heart Defects
  4. 4.1.4 Valvular Heart Disease
2. 4.2 Healthcare, BY End Use (USD Billion)
  1. 4.2.1 Hospitals
  2. 4.2.2 Specialized Heart Clinics
  3. 4.2.3 Transplant Centers
3. 4.3 Healthcare, BY Type of Donor (USD Billion)
  1. 4.3.1 Living Donor
  2. 4.3.2 Deceased Donor
4. 4.4 Healthcare, BY Age Group (USD Billion)
  1. 4.4.1 Pediatric
  2. 4.4.2 Adult
  3. 4.4.3 Geriatric
5. 4.5 Healthcare, BY Gender (USD Billion)
  1. 4.5.1 Male
  2. 4.5.2 Female
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Terumo Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cardinal Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Baxter International (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Edwards Lifesciences (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sorin Group (IT)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Janssen Pharmaceuticals (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY TYPE OF DONOR
6. 6.6 US MARKET ANALYSIS BY AGE GROUP
7. 6.7 US MARKET ANALYSIS BY GENDER
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY END USE
10. 6.10 CANADA MARKET ANALYSIS BY TYPE OF DONOR
11. 6.11 CANADA MARKET ANALYSIS BY AGE GROUP
12. 6.12 CANADA MARKET ANALYSIS BY GENDER
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY END USE
16. 6.16 GERMANY MARKET ANALYSIS BY TYPE OF DONOR
17. 6.17 GERMANY MARKET ANALYSIS BY AGE GROUP
18. 6.18 GERMANY MARKET ANALYSIS BY GENDER
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY END USE
21. 6.21 UK MARKET ANALYSIS BY TYPE OF DONOR
22. 6.22 UK MARKET ANALYSIS BY AGE GROUP
23. 6.23 UK MARKET ANALYSIS BY GENDER
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY END USE
26. 6.26 FRANCE MARKET ANALYSIS BY TYPE OF DONOR
27. 6.27 FRANCE MARKET ANALYSIS BY AGE GROUP
28. 6.28 FRANCE MARKET ANALYSIS BY GENDER
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY END USE
31. 6.31 RUSSIA MARKET ANALYSIS BY TYPE OF DONOR
32. 6.32 RUSSIA MARKET ANALYSIS BY AGE GROUP
33. 6.33 RUSSIA MARKET ANALYSIS BY GENDER
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY END USE
36. 6.36 ITALY MARKET ANALYSIS BY TYPE OF DONOR
37. 6.37 ITALY MARKET ANALYSIS BY AGE GROUP
38. 6.38 ITALY MARKET ANALYSIS BY GENDER
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY END USE
41. 6.41 SPAIN MARKET ANALYSIS BY TYPE OF DONOR
42. 6.42 SPAIN MARKET ANALYSIS BY AGE GROUP
43. 6.43 SPAIN MARKET ANALYSIS BY GENDER
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY TYPE OF DONOR
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY GENDER
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY END USE
52. 6.52 CHINA MARKET ANALYSIS BY TYPE OF DONOR
53. 6.53 CHINA MARKET ANALYSIS BY AGE GROUP
54. 6.54 CHINA MARKET ANALYSIS BY GENDER
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY END USE
57. 6.57 INDIA MARKET ANALYSIS BY TYPE OF DONOR
58. 6.58 INDIA MARKET ANALYSIS BY AGE GROUP
59. 6.59 INDIA MARKET ANALYSIS BY GENDER
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY END USE
62. 6.62 JAPAN MARKET ANALYSIS BY TYPE OF DONOR
63. 6.63 JAPAN MARKET ANALYSIS BY AGE GROUP
64. 6.64 JAPAN MARKET ANALYSIS BY GENDER
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY TYPE OF DONOR
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY GENDER
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY END USE
72. 6.72 MALAYSIA MARKET ANALYSIS BY TYPE OF DONOR
73. 6.73 MALAYSIA MARKET ANALYSIS BY AGE GROUP
74. 6.74 MALAYSIA MARKET ANALYSIS BY GENDER
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY END USE
77. 6.77 THAILAND MARKET ANALYSIS BY TYPE OF DONOR
78. 6.78 THAILAND MARKET ANALYSIS BY AGE GROUP
79. 6.79 THAILAND MARKET ANALYSIS BY GENDER
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY END USE
82. 6.82 INDONESIA MARKET ANALYSIS BY TYPE OF DONOR
83. 6.83 INDONESIA MARKET ANALYSIS BY AGE GROUP
84. 6.84 INDONESIA MARKET ANALYSIS BY GENDER
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY END USE
87. 6.87 REST OF APAC MARKET ANALYSIS BY TYPE OF DONOR
88. 6.88 REST OF APAC MARKET ANALYSIS BY AGE GROUP
89. 6.89 REST OF APAC MARKET ANALYSIS BY GENDER
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY END USE
93. 6.93 BRAZIL MARKET ANALYSIS BY TYPE OF DONOR
94. 6.94 BRAZIL MARKET ANALYSIS BY AGE GROUP
95. 6.95 BRAZIL MARKET ANALYSIS BY GENDER
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY END USE
98. 6.98 MEXICO MARKET ANALYSIS BY TYPE OF DONOR
99. 6.99 MEXICO MARKET ANALYSIS BY AGE GROUP
100. 6.100 MEXICO MARKET ANALYSIS BY GENDER
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY END USE
103. 6.103 ARGENTINA MARKET ANALYSIS BY TYPE OF DONOR
104. 6.104 ARGENTINA MARKET ANALYSIS BY AGE GROUP
105. 6.105 ARGENTINA MARKET ANALYSIS BY GENDER
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF DONOR
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENDER
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF DONOR
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY GENDER
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF DONOR
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY GENDER
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY END USE
124. 6.124 REST OF MEA MARKET ANALYSIS BY TYPE OF DONOR
125. 6.125 REST OF MEA MARKET ANALYSIS BY AGE GROUP
126. 6.126 REST OF MEA MARKET ANALYSIS BY GENDER
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY TYPE OF DONOR, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY TYPE OF DONOR, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY GENDER, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.2.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.2.5 BY GENDER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.3.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.3.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.3.5 BY GENDER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.4.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.4.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.4.5 BY GENDER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.5.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.5.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.5.5 BY GENDER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.6.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.6.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.6.5 BY GENDER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.7.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.7.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.7.5 BY GENDER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.8.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.8.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.8.5 BY GENDER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.9.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.9.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.9.5 BY GENDER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.10.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.10.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.10.5 BY GENDER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.11.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.11.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.11.5 BY GENDER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.12.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.12.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.12.5 BY GENDER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.13.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.13.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.13.5 BY GENDER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.14.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.14.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.14.5 BY GENDER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.15.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.15.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.15.5 BY GENDER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.16.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.16.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.16.5 BY GENDER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.17.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.17.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.17.5 BY GENDER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.18.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.18.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.18.5 BY GENDER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.19.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.19.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.19.5 BY GENDER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.20.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.20.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.20.5 BY GENDER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.21.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.21.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.21.5 BY GENDER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.22.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.22.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.22.5 BY GENDER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.23.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.23.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.23.5 BY GENDER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.24.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.24.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.24.5 BY GENDER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.25.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.25.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.25.5 BY GENDER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.26.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.26.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.26.5 BY GENDER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.27.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.27.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.27.5 BY GENDER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.28.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.28.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.28.5 BY GENDER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.29.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.29.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.29.5 BY GENDER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.30.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
  4. 7.30.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.30.5 BY GENDER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Heart Transplant Market Segmentation

Heart Transplant Market By Application (USD Billion, 2025-2035)

Cardiac Failure
Coronary Artery Disease
Congenital Heart Defects
Valvular Heart Disease

Heart Transplant Market By End Use (USD Billion, 2025-2035)

Hospitals
Specialized Heart Clinics
Transplant Centers

Heart Transplant Market By Type of Donor (USD Billion, 2025-2035)

Living Donor
Deceased Donor

Heart Transplant Market By Age Group (USD Billion, 2025-2035)

Pediatric
Adult
Geriatric

Heart Transplant Market By Gender (USD Billion, 2025-2035)

Male
Female

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”